Upregulated glycolytic level in both CD4+ T and CD8+ T cells can activate branching pathways such as PPP and serine-one carbon pathway to generate enough intermediates to support biosynthesis and their anti-tumor functions. This evidence concerns the gene CD4 and neoplasm.